Found 21 matching trials
Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in OSA PHASE2 This trial is a randomized, double-blind, placebo-controlled, crossover stu...
Show More Location
Maastricht University
Learn More & Join Trial
Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in Narcolepsy PHASE2 This trial is a randomized, double-blind, placebo-controlled, crossover stu...
Show More Location
Maastricht University
Learn More & Join Trial
Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol PHASE3 ENGAGE (Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Di...
Show More Location
Clinical Research Site
Learn More & Join Trial
Solriamfetol in Binge Eating Disorder PHASE4 The goal of this project is to evaluate the efficacy and tolerability of th...
Show More Location
Lindner Center of HOPE
Learn More & Join Trial
"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA" PHASE3 This trial is a 12 week, randomized, double-blind, placebo controlled, mult...
Show More Location
Pulmonary Associates
Learn More & Join Trial
Efficacy and Tolerance of Solriamfetol in Patients Affected with Idiopathic Hypersomnia. PHASE2 This Phase II clinical trial is a monocenter, double-blind, randomized, pla...
Show More Location
University Hospital of Montpellier
Learn More & Join Trial
"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in Narcolepsy" PHASE3 This trial is a 12-week, randomized, double-blind, placebo controlled, mult...
Show More Location
Sleep Disorders Center of Alabama
Learn More & Join Trial
A 4-Week Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness PHASE2 This study is a 4-week, multicenter, randomized, double-blind, placebo-cont...
Show More Location
Southern California Institute For Respiratory Diseases, Inc.
Learn More & Join Trial
Evaluate Sunosi® PK in Breast Milk and Plasma of Healthy Postpartum Women Following Single Dose Oral Administration PHASE1 The purpose of study JZP110-401 is to evaluate solriamfetol pharmacokinetic...
Show More Location
M3-Wake Research, Inc.
Learn More & Join Trial
Solriamfetol's Effect on Cognitive Health in Apnea Participants During a Randomized Placebo-controlled Study PHASE4 The purpose of study JZP110-405 is to determine whether solriamfetol is eff...
Show More Location
Southern California Institute for Respiratory Disease
Learn More & Join Trial